Paul Denslow

Chief Executive Officer at Intus Biosciences LLC

Finance

Health Services

Profile

Paul Denslow currently works as the Chief Executive Officer & Director at Intus Biosciences LLC.
He has also worked as the Head-Forex Sales at Standard Chartered Bank (New York Branch) from 2014 to present.

Paul Denslow active positions

Companies	Position	Start
Standard Chartered Bank (New York Branch) Standard Chartered Bank (New York Branch) Regional BanksFinance Standard Chartered Bank (New York) provides commercial banking services. Its products and services include cash management, foreign exchange and treasury products, commodity finance, and structured import and export finance services. The company was founded in 1902 and is headquartered in New York, NY.	Sales & Marketing	2014-07-28
Intus Biosciences LLC Intus Biosciences LLC Medical/Nursing ServicesHealth Services Intus Biosciences LLC provides the first rapid and cost-effective method for looking at the micro-biome at sufficient resolution to use as a diagnostic test. The company was founded by Mark Driscoll and Thomas Jarvie in 2015 and is headquartered in Farmington, CT.	Chief Executive Officer	-

All active positions of Paul Denslow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Denslow's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Standard Chartered Bank (New York Branch) Standard Chartered Bank (New York Branch) Regional BanksFinance Standard Chartered Bank (New York) provides commercial banking services. Its products and services include cash management, foreign exchange and treasury products, commodity finance, and structured import and export finance services. The company was founded in 1902 and is headquartered in New York, NY.	Finance
Intus Biosciences LLC Intus Biosciences LLC Medical/Nursing ServicesHealth Services Intus Biosciences LLC provides the first rapid and cost-effective method for looking at the micro-biome at sufficient resolution to use as a diagnostic test. The company was founded by Mark Driscoll and Thomas Jarvie in 2015 and is headquartered in Farmington, CT.	Health Services